Last reviewed: July 3, 2026

Last updated: July 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy (semaglutide) is a GLP-1 receptor agonist originally developed for type 2 diabetes that was FDA-approved in 2021 specifically for chronic weight management in adults with obesity or overweight with weight-related conditions. Multiple healthcare provider types can legally prescribe Wegovy, but availability, cost, and insurance coverage vary widely. PlexusDx offers a direct-to-patient model with compounded semaglutide injections that eliminates insurance barriers and provides medically supervised dosing at a flat monthly rate.

Types of Doctors Who Prescribe Semaglutide for Weight Loss

Primary care physicians—including family medicine doctors, internists, and general practitioners—are the most common prescribers of weight loss medications. These doctors see patients regularly for annual physicals and chronic disease management, making them well-positioned to assess metabolic health, screen for contraindications, and monitor treatment response over time. They typically manage baseline blood sugar levels, kidney function, and cardiovascular risk factors that influence semaglutide eligibility.

Endocrinologists specializing in metabolic and hormone disorders frequently prescribe GLP-1 medications because they understand insulin signaling, glucose homeostasis, and how semaglutide affects pancreatic beta cells. Cardiologists also prescribe semaglutide in clinical practice, particularly for patients with established heart disease or diabetes, since GLP-1 agonists have demonstrated cardiovascular benefits in major trials. Obesity medicine specialists—a growing subspecialty—bring advanced training in behavioral psychology, nutritional biochemistry, and medication management for weight disorders.

Nurse practitioners (NPs) and physician assistants (PAs) licensed in states that permit independent or collaborative prescribing can legally order semaglutide under their scope of practice. Many telehealth platforms and weight loss clinics employ NPs and PAs as the primary prescribing team, supported by supervising physicians. The clinical outcomes from NP and PA-managed GLP-1 therapy are equivalent to physician-led care when protocols include appropriate screening and follow-up monitoring.

Insurance vs. Direct-Pay Models for Semaglutide Access

Brand-name Wegovy through traditional insurance requires prior authorization, faces supply shortages, and often demands step-therapy requirements (trying other drugs first). Insurance formularies limit Wegovy to patients meeting specific BMI thresholds or comorbidity criteria, and copays typically range from $250 to $500 monthly depending on plan tier. Many patients find insurance-based access unreliable due to prior authorization denials or unexpected coverage terminations.

Direct-pay compounded semaglutide bypasses insurance gatekeeping and offers transparent, flat monthly pricing with no surprise costs. PlexusDx delivers compounded semaglutide injections starting at $149 per month from licensed 503A compounding pharmacies nationwide, with no membership fees, no insurance required, and HSA/FSA eligibility. This model removes authorization delays and allows patients to start treatment within days rather than weeks, giving prescribers immediate medication access to counsel patients on injection technique and side effect expectations.

How to Find a Licensed Prescriber for Weight Loss Treatment

Patients seeking semaglutide prescriptions can start with their primary care doctor, who often has weight loss expertise or can refer to an obesity medicine specialist in-network. Online directories like the American Board of Obesity Medicine (ABOM) and the Obesity Medicine Association (OMA) list certified specialists by state and geographic region. Telehealth platforms offering weight loss programs employ credentialed prescribers who evaluate patients remotely via video consultation, allowing access regardless of local specialist availability.

PlexusDx connects patients with licensed prescribers across all 50 states who understand compounded GLP-1 therapy and can provide ongoing medical supervision. The prescriber relationship includes baseline metabolic screening, dose titration protocols, and regular follow-up labs to assess kidney function and cardiovascular markers. PlexusDx also offers the Precision Peptide Genetic Test ($99 add-on after first month) to identify genetic variants in peptide pathways that predict individual treatment response, allowing prescribers to personalize initial dosing and medication selection.

Medical Supervision Requirements and Patient Safety Standards

Any legitimate semaglutide prescription requires a physician consultation to confirm the patient does not have a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia syndrome type 2 (MEN2), or acute pancreatitis—all contraindications listed in FDA labeling. The prescriber must verify baseline kidney function via creatinine and eGFR, assess for diabetic retinopathy in patients with existing diabetes, and confirm the patient understands the injection technique and recognizes gastrointestinal warning signs. These screening steps take 15–30 minutes and are standard of care regardless of whether the medication is brand-name or compounded.

Compounded semaglutide from licensed 503A pharmacies follows identical pharmacopeial standards as brand Wegovy in terms of sterility, potency, and purity. PlexusDx requires prescriber documentation of baseline labs, maintains medical records linked to each prescription, and coordinates follow-up assessments at weeks 4, 8, and 12 to evaluate efficacy and adverse events. This supervision model ensures patient safety while eliminating insurance friction and delivering medication at a flat rate: your dose may need to go up, but your price won't.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can my primary care doctor prescribe semaglutide for weight loss?

Yes, primary care physicians are fully licensed to prescribe semaglutide and often do so as part of comprehensive metabolic care. Your family medicine doctor or internist can evaluate your eligibility, screen for contraindications, and monitor your response with regular labs and check-ins. If your primary care doctor is unfamiliar with GLP-1 therapy, they can refer you to PlexusDx, which pairs you with an experienced prescriber nationwide.

What clinical evidence supports semaglutide for weight loss in non-diabetic patients?

The STEP trials (Semaglutide Treatment Effect in People with Obesity) enrolled over 4,500 non-diabetic adults and showed semaglutide 2.4 mg weekly produced average weight loss of 16–18% over 68 weeks, compared to 2–3% with placebo. Cardiovascular benefits including lower blood pressure and reduced inflammatory markers were observed even in patients without baseline diabetes. These outcomes demonstrate semaglutide's efficacy for pure obesity independent of glucose control.

How much does compounded semaglutide cost with PlexusDx compared to insurance?

PlexusDx offers compounded semaglutide injections at a flat rate starting at $149 per month—no insurance needed, no prior authorization delays, and no surprise copays. Insurance plans typically charge $250–$500 monthly out-of-pocket plus may deny coverage entirely. PlexusDx pricing remains fixed across all dose levels, and HSA/FSA accounts can pay directly, making it the most transparent and accessible option.

Are compounded semaglutide and Wegovy chemically identical?

Compounded semaglutide is the same active pharmaceutical ingredient (GLP-1 receptor agonist) as Wegovy, sourced from licensed 503A compounding pharmacies that follow FDA sterility and potency standards. The difference is the delivery method: brand Wegovy uses a proprietary auto-injector pen, while compounded semaglutide uses a standard insulin syringe. Clinical efficacy is equivalent when compounding meets quality standards, and PlexusDx ensures each pharmacy is state-licensed and regularly audited.

How does the Precision Peptide Genetic Test help personalize my semaglutide dosing?

PlexusDx Precision Peptide Genetic Test identifies variants in four key genes—GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313—that influence how your body responds to GLP-1 therapy and weight regulation. These insights help your prescriber predict your likely starting dose, expected weight loss trajectory, and risk of specific side effects, allowing earlier dose escalation if needed. The test costs $99 as an add-on after your first month of treatment and maps 14 pathways and 150+ genetic insights.

Related Reading

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves